These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. P2X7 receptors: role in bone cell formation and function. Agrawal A; Gartland A J Mol Endocrinol; 2015 Apr; 54(2):R75-88. PubMed ID: 25591582 [TBL] [Abstract][Full Text] [Related]
23. P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells. Wilkaniec A; Cieślik M; Murawska E; Babiec L; Gąssowska-Dobrowolska M; Pałasz E; Jęśko H; Adamczyk A Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486485 [TBL] [Abstract][Full Text] [Related]
24. Carboxyl terminus of Pannexin-1 plays a crucial role in P2X7 receptor-mediated signaling. Purohit R; Bera AK Biochem Biophys Res Commun; 2023 Jul; 664():20-26. PubMed ID: 37130457 [TBL] [Abstract][Full Text] [Related]
25. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Humphreys BD; Virginio C; Surprenant A; Rice J; Dubyak GR Mol Pharmacol; 1998 Jul; 54(1):22-32. PubMed ID: 9658186 [TBL] [Abstract][Full Text] [Related]
26. The purinergic receptor P2X7 role in control of Dengue virus-2 infection and cytokine/chemokine production in infected human monocytes. Corrêa G; de A Lindenberg C; Fernandes-Santos C; Gandini M; Petitinga Paiva F; Coutinho-Silva R; F Kubelka C Immunobiology; 2016 Jul; 221(7):794-802. PubMed ID: 26969484 [TBL] [Abstract][Full Text] [Related]
27. Extracellular ATP enhances radiation-induced brain injury through microglial activation and paracrine signaling via P2X7 receptor. Xu P; Xu Y; Hu B; Wang J; Pan R; Murugan M; Wu LJ; Tang Y Brain Behav Immun; 2015 Nov; 50():87-100. PubMed ID: 26122280 [TBL] [Abstract][Full Text] [Related]
28. The C-terminus of human nucleotide receptor P2X7 is critical for receptor oligomerization and N-linked glycosylation. Wickert LE; Blanchette JB; Waldschmidt NV; Bertics PJ; Denu JM; Denlinger LC; Lenertz LY PLoS One; 2013; 8(5):e63789. PubMed ID: 23691096 [TBL] [Abstract][Full Text] [Related]
29. A central role for P2X7 receptors in human microglia. Janks L; Sharma CVR; Egan TM J Neuroinflammation; 2018 Nov; 15(1):325. PubMed ID: 30463629 [TBL] [Abstract][Full Text] [Related]
30. Purinergic P2X7 receptor as a potential therapeutic target in depression. Qi W; Jin X; Guan W Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270 [TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide inhibits the channel activity of the P2X7 receptor. Leiva-Salcedo E; Coddou C; Rodríguez FE; Penna A; Lopez X; Neira T; Fernández R; Imarai M; Rios M; Escobar J; Montoya M; Huidobro-Toro JP; Escobar A; Acuña-Castillo C Mediators Inflamm; 2011; 2011():152625. PubMed ID: 21941410 [TBL] [Abstract][Full Text] [Related]
32. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays. Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620 [TBL] [Abstract][Full Text] [Related]
33. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival. Gehring MP; Kipper F; Nicoletti NF; Sperotto ND; Zanin R; Tamajusuku AS; Flores DG; Meurer L; Roesler R; Filho AB; Lenz G; Campos MM; Morrone FB Int J Biochem Cell Biol; 2015 Nov; 68():92-100. PubMed ID: 26358881 [TBL] [Abstract][Full Text] [Related]
34. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor. Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492 [TBL] [Abstract][Full Text] [Related]
35. Homodimeric anoctamin-1, but not homodimeric anoctamin-6, is activated by calcium increases mediated by the P2Y1 and P2X7 receptors. Stolz M; Klapperstück M; Kendzierski T; Detro-Dassen S; Panning A; Schmalzing G; Markwardt F Pflugers Arch; 2015 Oct; 467(10):2121-40. PubMed ID: 25592660 [TBL] [Abstract][Full Text] [Related]
36. P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. Verhoef PA; Estacion M; Schilling W; Dubyak GR J Immunol; 2003 Jun; 170(11):5728-38. PubMed ID: 12759456 [TBL] [Abstract][Full Text] [Related]
37. Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells. Ziberi S; Zuccarini M; Carluccio M; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Di Iorio P; Ciccarelli R Cells; 2019 Dec; 9(1):. PubMed ID: 31905754 [TBL] [Abstract][Full Text] [Related]
38. Roles of purinergic P2X McLarnon JG Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012 [TBL] [Abstract][Full Text] [Related]
39. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases. Zheng H; Liu Q; Zhou S; Luo H; Zhang W Front Immunol; 2024; 15():1345625. PubMed ID: 38370420 [TBL] [Abstract][Full Text] [Related]
40. Purinergic P2X7R as a potential target for pancreatic cancer. Yu Q; Wang X; Li X; Bai X; Zhao R; Peng X Clin Transl Oncol; 2023 Aug; 25(8):2297-2305. PubMed ID: 36856920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]